BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23724116)

  • 1. N-linked glycosylation supports cross-talk between receptor tyrosine kinases and androgen receptor.
    Itkonen HM; Mills IG
    PLoS One; 2013; 8(5):e65016. PubMed ID: 23724116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.
    Pandini G; Mineo R; Frasca F; Roberts CT; Marcelli M; Vigneri R; Belfiore A
    Cancer Res; 2005 Mar; 65(5):1849-57. PubMed ID: 15753383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UAP1 is overexpressed in prostate cancer and is protective against inhibitors of N-linked glycosylation.
    Itkonen HM; Engedal N; Babaie E; Luhr M; Guldvik IJ; Minner S; Hohloch J; Tsourlakis MC; Schlomm T; Mills IG
    Oncogene; 2015 Jul; 34(28):3744-50. PubMed ID: 25241896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of nordihydroguaiaretic acid (NDGA) on the IGF-1 receptor and androgen dependent growth of LAPC-4 prostate cancer cells.
    Ryan CJ; Zavodovskaya M; Youngren JF; Campbell M; Diamond M; Jones J; Shiry L; Allan G; Maddux BA; Goldfine ID
    Prostate; 2008 Aug; 68(11):1232-40. PubMed ID: 18491370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zyflamend reduces the expression of androgen receptor in a model of castrate-resistant prostate cancer.
    Huang EC; Chen G; Baek SJ; McEntee MF; Collier JJ; Minkin S; Biggerstaff J; Whelan J
    Nutr Cancer; 2011 Nov; 63(8):1287-96. PubMed ID: 21958043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of insulin-like growth factor-I receptor gene expression by wild type and mutant androgen receptor in prostate cancer cells.
    Schayek H; Seti H; Greenberg NM; Sun S; Werner H; Plymate SR
    Mol Cell Endocrinol; 2010 Jul; 323(2):239-45. PubMed ID: 20417685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studying N-linked glycosylation of receptor tyrosine kinases.
    Itkonen HM; Mills IG
    Methods Mol Biol; 2015; 1233():103-9. PubMed ID: 25319893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mevalonic acid is limiting for N-linked glycosylation and translocation of the insulin-like growth factor-1 receptor to the cell surface. Evidence for a new link between 3-hydroxy-3-methylglutaryl-coenzyme a reductase and cell growth.
    Carlberg M; Dricu A; Blegen H; Wang M; Hjertman M; Zickert P; Höög A; Larsson O
    J Biol Chem; 1996 Jul; 271(29):17453-62. PubMed ID: 8663239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor suppressor BRCA1 is expressed in prostate cancer and controls insulin-like growth factor I receptor (IGF-IR) gene transcription in an androgen receptor-dependent manner.
    Schayek H; Haugk K; Sun S; True LD; Plymate SR; Werner H
    Clin Cancer Res; 2009 Mar; 15(5):1558-65. PubMed ID: 19223505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth Modulation of Diabetic Factors and Antidiabetic Drugs on Prostate Cancer Cell Lines.
    Chien SW; Kuo DY; Liao JM; Wang PS; Yu CH
    Chin J Physiol; 2016 Apr; 59(2):109-18. PubMed ID: 27080466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin inhibits androgen-induced IGF-IR up-regulation in prostate cancer cells by disrupting membrane-initiated androgen signaling.
    Malaguarnera R; Sacco A; Morcavallo A; Squatrito S; Migliaccio A; Morrione A; Maggiolini M; Belfiore A
    Endocrinology; 2014 Apr; 155(4):1207-21. PubMed ID: 24437490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of IGF signaling and the androgen receptor in prostate cancer progression.
    Wu JD; Haugk K; Woodke L; Nelson P; Coleman I; Plymate SR
    J Cell Biochem; 2006 Oct; 99(2):392-401. PubMed ID: 16639715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT; Le H; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation.
    Mahajan NP; Liu Y; Majumder S; Warren MR; Parker CE; Mohler JL; Earp HS; Whang YE
    Proc Natl Acad Sci U S A; 2007 May; 104(20):8438-43. PubMed ID: 17494760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progression.
    Dozmorov MG; Azzarello JT; Wren JD; Fung KM; Yang Q; Davis JS; Hurst RE; Culkin DJ; Penning TM; Lin HK
    BMC Cancer; 2010 Dec; 10():672. PubMed ID: 21134280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor overexpression in prostate cancer in type 2 diabetes.
    Lutz SZ; Hennenlotter J; Scharpf MO; Sailer C; Fritsche L; Schmid V; Kantartzis K; Wagner R; Lehmann R; Berti L; Peter A; Staiger H; Fritsche A; Fend F; Todenhöfer T; Stenzl A; Häring HU; Heni M
    Mol Metab; 2018 Feb; 8():158-166. PubMed ID: 29249638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.
    Culig Z; Hobisch A; Cronauer MV; Radmayr C; Trapman J; Hittmair A; Bartsch G; Klocker H
    Cancer Res; 1994 Oct; 54(20):5474-8. PubMed ID: 7522959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global methylation analysis identifies PITX2 as an upstream regulator of the androgen receptor and IGF-I receptor genes in prostate cancer.
    Schayek H; Bentov I; Jacob-Hirsch J; Yeung C; Khanna C; Helman LJ; Plymate SR; Werner H
    Horm Metab Res; 2012 Jun; 44(7):511-9. PubMed ID: 22495974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential action of IGF-1 and EGF on androgen receptor nuclear transfer and transactivation in normal and cancer human prostate cell lines.
    Orio F; Térouanne B; Georget V; Lumbroso S; Avances C; Siatka C; Sultan C
    Mol Cell Endocrinol; 2002 Dec; 198(1-2):105-14. PubMed ID: 12573820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen-induced PSA expression requires not only activation of AR but also endogenous IGF-I or IGF-I/PI3K/Akt signaling in human prostate cancer epithelial cells.
    Liu X; Choi RY; Jawad SM; Arnold JT
    Prostate; 2011 May; 71(7):766-77. PubMed ID: 21031436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.